Clinical Trial Update: Repeat Immunoadsorption Post Covid ME/CFS

View source ↗

Summary

A completed clinical trial at Charite University Berlin evaluated repeat immunoadsorption as a treatment for Post-COVID myalgic encephalomyelitis/chronic fatigu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myalgic Encephalomyelitis Chronic Fatigue Syndrome
• Post-acute Sequelae of Sars-cov-2 Infection

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Post-COVID ME/CFS | Status: COMPLETED